Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 1.
doi: 10.1097/SLA.0000000000006866. Online ahead of print.

Living Donor Liver Transplantation reduced Waitlist Mortality in Acute-on-chronic Liver Failure

Affiliations

Living Donor Liver Transplantation reduced Waitlist Mortality in Acute-on-chronic Liver Failure

Tiffany Cho-LamWong et al. Ann Surg. .

Abstract

Objective: To compare intention-to-treat (ITT) and post-transplant outcomes of living donor liver transplant (LDLT) and deceased donor liver transplant (DDLT) in patients with acute-on-chronic liver failure (ACLF).

Summary background data: Limited data exist comparing LDLT and DDLT outcomes in ACLF, particularly addressing waitlist mortality.

Methods: Retrospective analysis of all ACLF patients listed for transplant (2008-2023). Patients with living donors were categorized as intention-to-treat LDLT (ITT-LDLT) group and others as ITT-DDLT group. Primary outcome was to compare ITT-overall survival (ITT-OS), defined as survival from listing to death. Secondary outcomes included waitlist outcomes, post-transplant complication and long-term survival.

Results: 270 patients were accepted for transplant (ITT-LDLT n=127, ITT-DDLT n=143) with similar clinical characteristics at listing. ITT-LDLT achieved superior ITT-OS, with 92.9% survival at 3 months vs. 67.1% for ITT-DDLT (P<0.001), driven by higher transplant rates (94.5% vs. 53.8%, P<0.001) and shorter waiting times. ACLF grade 2 and 3 patients had the greatest survival benefit in ITT analysis. Futile waitlist outcomes, defined as death or delisting were more common in ITT-DDLT (4.7% vs. 35.7%, P<0.001). Post-transplant outcomes were comparable; 30-day mortality (2.0% vs. 1.0%, P=0.62), severe complication (28.6% vs. 33.3%, P=0.47) and 5-year survival (74.5% vs. 74.7%, P=0.46). Even for ACLF grade 2 and 3, LDLT achieved a 5-year survival at 87.2% and 68.0% respectively. Older age, higher ACLF grade and ITT-DDLT predicted waitlist futility. Neither ACLF grades nor transplant type predicted graft survival.

Conclusion: ITT-LDLT improved ITT-OS especially in ACLF grade 2/3 cohort and provided similar perioperative and long-term outcomes to DDLT.

Keywords: acute-on-chronic liver failure; deceased donor liver transplant; liver transplant; living donor liver transplant; outcomes.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors of this manuscript have no conflicts of interest to disclose.

Similar articles

LinkOut - more resources